India

Bharat Biotech’s “iNCOVACC” Intranasal Vaccine Price Out Now

Bharat Biotech’s intranasal coronavirus vaccine costs have been announced.

A single dosage of Bharat Biotech’s intranasal vaccine iNCOVACC, which was authorised for inclusion in India’s COVID-19 immunisation programme last week, would cost Rs 800, excluding the 5% Goods and Services Tax (GST) at private hospitals.
The nasal vaccination was authorised by the government last Friday as India prepared to deal with any crisis that arises as a result of the worldwide spike in coronavirus infections. It will be used as a heterologous booster and will be offered first in private institutions.

Where to apply for nasal vaccine?

Starting today, the vaccination will be available through the CoWIN app. In this context, the CoWIN platform will also be changed. Simply check in to your CoWIN account and apply for a vaccination slot. The vaccine will be offered in private hospitals beginning today and will be included in Covid-19 immunisation campaigns.

Who is eligible for nasal vaccine?

Those above the age of 18 can get the iNCOVACC nasal vaccine, which has been licenced by the Government of India and will be used as a heterologous booster dose.
When compared to injectable immunisations, nasal vaccines provide several advantages. Aside from the simplicity of storage, delivery, and waste creation, nasal vaccinations also give protection at the virus’s entrance locations – the nose or upper respiratory tract.

Also Read: COVID Mock Drills TO Take Place All Over India Today

Companies That Took Part in the making

The vaccine was created in collaboration with Washington University in St. Louis, which conceived and produced the recombinant adenoviral vectored construct and tested its effectiveness in preclinical tests.

Bharat Biotech developed products for preclinical safety review, large-scale manufacturing scale up, formulation and delivery device development, and human clinical trials.

The Government of India supported part of the product development and clinical testing through the Department of Biotechnology’s Covid Suraksha programme.

The government has encouraged people who are eligible to take the preventive dose and practise Covid-appropriate behaviour, such as masking and social distance.

On Thursday, Prime Minister Narendra Modi warned people not to be complacent and advised them to wear masks in crowded locations, while also urging officials to increase surveillance procedures, particularly at international airports.

Parth Kakade

Recent Posts

Acharya Pramod Krishnam Slams Congress Over ‘Internal Emergency’ Allegation

Acharya Pramod Krishnam, stirred political debate by claiming an 'internal emergency' still exists within the…

16 mins ago

MRM Meeting: Pledge for Global Peace, Green India, De-addiction & Democratic Integrity

Taking a crucial step toward positive transformation, social reform, and global peace, the Muslim Rashtriya…

22 mins ago

India To Host 2029 World Police & Fire Games; Amit Shah Hails Global Recognition

India has been chosen to host the prestigious 2029 World Police and Fire Games in…

32 mins ago

Seeing The Lord Among Devotees Is The Pinnacle Of Humility: Gautam Adani At Rath Yatra

Gautam Adani, along with his wife and Karan, participated in the Rath Yatra in Puri,…

3 hours ago

PM Modi Interacts With Group Captain Shubhanshu Shukla Aboard The ISS

PM Narendra Modi interacted with Group Captain Shubhanshu Shukla, the first Indian to reach the…

4 hours ago

Gautam Adani, Family Participate In Puri Rath Yatra; Launch Massive ‘Prasad Seva’ Initiative

Gautam Adani, along with his wife Priti Adani and son Karan Adani, joined thousands of…

5 hours ago